Provided herein are devices, systems, and methods for biological sample collection. In particular, provided herein are devices, systems, and methods that employ small, hand-held devices that collect small volumes of biological samples, such as vitreous from the eye, for diagnostic, research, and other purposes.
Liquid biopsies are increasingly being utilized in diverse medical contexts as a minimally invasive approach to provide real-time information about a patient's disease status. By extracting and analyzing a sample of a given biological fluid, clinicians gain information about the tissue with which that fluid was in contact. Primarily liquid samples, such as blood, urine, and saliva have many suitable options for collection. Other sample types, such as the vitreous, a gelatinous fluid that fills the posterior segment of the eye, present more significant challenges. The vitreous lies in juxtaposition to the light-sensing retina, and liquid vitreous biopsies can thus provide information about vision-threatening retinal diseases. However, the challenges of collecting vitreous samples have limited the availability of diagnostic applications. Moreover, the retina cannot be biopsied in most cases so vitreous biopsies have high clinical importance.
Currently, two types of devices exist for removing vitreous from the eye, one optimized for use in the operating room, and the other optimized for use in clinical settings. Modern operating room devices are based on the vitreous infusion suction cutter, which was designed in the 1970s for vitrectomy surgeries. These operating room units are optimized for removal of the full volume of vitreous and incorporate additional tools to aid vitrectomy surgery such as infusion and illumination. Operating room based vitreous cutting devices are large, difficult to transport, and expensive. Portable vitreous cutters designed for clinical use were developed in the 1990s and partially overcome these drawbacks. Although smaller and slightly lower in cost than their operating room counterparts, these clinical devices have the disadvantages of requiring power cords, two users (an operator and assistant), and simultaneous infusion (administration of a material into the eye to compensate for the material removed). Like the operating room vitreous cutter, the clinical vitreous cutter is also optimized for large-volume sample extraction only.
The high cost, large size, and limited capacity to minimize sample volume of the current operating room and clinical vitreous cutter models impose a steep barrier to broadening the use of liquid vitreous biopsies in clinical settings. Improved devices, systems, and methods are needed.
Provided herein are devices, systems, and methods for biological sample collection. In particular, provided herein are devices, systems, and methods that employ small, hand-held devices that collect small volumes of biological samples, such as vitreous from the eye, for diagnostic, research, and other purposes.
The systems, devices, and methods are exemplified by collection of vitreous from the eye. It should be understood that the systems, devices, and methods, while particularly effective at vitreous sample collection, are not so limited. A wide variety of sample types may be collected.
With respect to vitreous collection, the systems, devices and methods overcome the unresolved barriers left by the prior art technologies. To overcome these barriers, in some embodiments, the devices herein provide low-cost, hand-held, disposable devices designed to remove a small (e.g., 1 mL or less, 500 uL or less, 250 μL or less, 100 μL or less) sample of vitreous that can then be analyzed for diagnostic purposes. In some embodiments, the devices use a small-gauge needle with cutting action, extracts a small volume of fluid, and requires no infusion component. Together, these design features confer simplification of the procedure for the operator and provide a safe mechanism for liquid vitreous biopsy in the clinical setting.
For example, in some embodiments, provided herein is a device or system comprising one or more or each of: a) a syringe, the syringe comprising a barrel having a longitudinal axis, the barrel comprising a sample collection volume; b) a needle connected to a distal end of the syringe at a needle hub, the needle having a lumen; c) a cutting tool positioned within the lumen of the needle; and d) an actuator that linearly or rotationally moves the cutting tool within the needle. In some embodiments, the actuator is outside the syringe barrel. In some embodiments, the actuator is located at the distal end of the needle hub.
In some embodiments, provided herein is a device or system comprising: a) a syringe comprising i) a cutting tool positioned within a needle lumen, the cutting tool having a proximal end comprising one or more permanent magnets, the cutting tool configured to linearly or rotationally move within the needle lumen, and ii) a barrel having a longitudinal axis, said barrel comprising a sample collection volume; and b) a motor (e.g., electromagnet motor) positioned outside of the syringe configured to linearly or rotationally move the cutting tool under magnetic force. In some embodiments, the motor is outside the syringe barrel. In some embodiments, the motor is located at the distal end of the needle hub.
In some embodiments, provided herein is a device or system comprising: a) a syringe comprising i) a cutting tool positioned within a needle lumen, the cutting tool having a proximal end comprising one or more or metal structures (e.g. squirrel cage or conductive loops), the cutting tool configured to linearly or rotationally move within the needle lumen, and ii) a barrel having a longitudinal axis, said barrel comprising a sample collection volume; and b) a motor positioned outside of the syringe configured to linearly or rotationally move the cutting tool under magnetic force. In some embodiments, the motor is outside the syringe barrel. In some embodiments, the motor is located at the distal end of the needle hub.
In some embodiments, the needle is a 20 gauge or smaller needle (e.g., 24 gauge, 26 gauge or smaller, etc.), hollow with a lumen. The needle may be any standard length (e.g., ⅜ inch to 3½ inch). In some embodiments the needle length is ½ inch. Any desired cutting tool may be employed. In some embodiments, the cutting tool comprises a drill bit (e.g., a twist drill bit). In some embodiments, the cutting tool has a distal end blade. In some embodiments, the cutting tool is configured as a needle within a needle. In some embodiments, the tip of the needle, and optionally, the tip of the cutting tool needle is closed. In some embodiments, the needle and cutting tool have an opening on the side that when aligned allows material to enter, and as the opening closes, it provides a cutting mechanism (guillotine). In some embodiments, the collection volume is 1 mL or less (e.g., 500 uL or less, 250 μL or less, 100 μL or less, etc.).
In some embodiments, the actuator comprises one or more magnet(s). The poles of the magnets may be perpendicular to the needle longitudinal axis for rotational motion or parallel (along) the needle longitudinal axis for linear movement.
In some embodiments, the actuator comprises a plurality of electromagnets positioned around the longitudinal axis. In some embodiments, the actuator comprises a plurality of electromagnets positioned along the longitudinal axis. In some embodiments, the plurality of electromagnets comprises 2 or more (e.g., three, four, five, six or more, etc.) electromagnets. In some embodiments, the plurality of electromagnets comprises four or more electromagnets. In some embodiments, the electromagnets are on the same or different support structure (e.g. stator rings or assemblies). In some embodiments, the electromagnets are on 2 or more support structures. In some embodiments, the support structures are slotted stators. In some embodiments, the actuator comprises a plurality of phase coils. In some embodiments, the actuator comprises one or more slotless stators. In some embodiments, the device is configured to alter a magnetic field by changing the polarity of the electromagnets. In some embodiments, the device is configured to alter a magnetic field by altering the physical position of the magnets or electromagnets.
In some embodiments, the motor comprises a plurality of electromagnets positioned around the longitudinal axis. In some embodiments, the motor comprises a plurality of electromagnets positioned along the longitudinal axis. In some embodiments, the plurality of electromagnets comprises 2 or more (e.g., three, four, five, six or more, etc.) electromagnets. In some embodiments, the plurality of electromagnets comprises four or more electromagnets. In some embodiments, the electromagnets are on the same or different support structure (e.g. stator rings or assemblies). In some embodiments, the electromagnets are on 2 or more support structures. In some embodiments, the support structures are slotted stators. In some embodiments, the motor comprises a plurality of phase coils. In some embodiments, the actuator comprises one or more slotless stators. In some embodiments, the device is configured to alter a magnetic field by changing the polarity the electromagnets. In some embodiments, the device is configured to alter a magnetic field by altering the physical position of the magnets or electromagnets.
In some embodiments, the device further comprises one or more permanent magnets. In some embodiments, the one or more permanent magnets are positioned inside of the barrel (e.g., attached to a proximal end of the cutting tool). In some embodiments, the one or more permanent magnets are positioned inside of the needle hub (e.g., attached to a proximal end of the cutting tool inside the needle hub). In some embodiments, the one or more permanent magnets are replaced by a metal structure (e.g. squirrel cage or other conductive loop structure) designed to produce an electromagnetic force (Lorentz forces) when a varying magnetic field is applied. In some embodiments, the device further comprises a spring or contravening force adjacent to the one or more permanent magnets or metal structure.
The actuator may be powered by any mechanism. In some embodiments, the actuator or motor is powered by a battery and the device comprises a battery compartment housing one or more batteries. In some embodiments, the device comprises a power cord. In some embodiments, the device or system comprises a switch or other control mechanism that activates the actuator.
Further provided herein are systems (e.g., kits) comprising the devices and one or more additional components. Additional components include, but are not limited to, power systems, packaging, instructions, labels, biological samples contained in the device (e.g., collected by the device), computer control systems, diagnostic reagents (e.g., to analyze a sample collected by the device), and the like.
Further provided herein are methods of collecting samples (e.g., biological samples such as vitreous samples) using the devices. In some embodiments, the method comprises: a) positioning a distal end of the needle into a region containing the sample to be collected; b) activating the actuator to rotate the cutting tool; and c) drawing sample into the collection volume. In some embodiments, the method further comprises at least one or all of: attaching a syringe to a needle hub; removing the syringe from the needle hub; attaching an injection fluid syringe to the needle hub, wherein the injection fluid syringe comprises a fluid to be injected; and injecting a fluid into the region. The injection fluid may comprise a pharmaceutical agent. In some embodiments, the method is carried out without infusing or injecting material into the sample location (e.g., eye).
To facilitate understanding of the invention, a number of terms are defined below.
As used herein, the term “sample” is used in its broadest sense. In one sense, it is meant to include a specimen obtained from any source, including biological and environmental samples. Biological samples may be obtained from animals (including humans) and encompass fluids, solids, tissues, and gases. Such examples are not however to be construed as limiting the sample types.
As used herein, the term “subject” refers to any animal (e.g., a mammal), including, but not limited to, humans, non-human primates, rodents, and the like. Typically, the terms “subject” and “patient” are used interchangeably herein in reference to a human subject.
As used herein, the term “non-human animals” refers to all non-human animals including, but are not limited to, vertebrates such as rodents, non-human primates, ovines, bovines, ruminants, lagomorphs, porcines, caprines, equines, canines, felines, ayes, etc.
A “syringe” is a device comprising a barrel, typically but not necessarily tube-shaped, for injecting or withdrawing a sample in a thin stream, typically through a hollow needle. Samples are injected or withdrawn via pressure, typically from a reciprocating pump (e.g., employing a piston or plunger). A plunger can be linearly pulled and pushed along the inside of the barrel, allowing the syringe to take in and expel liquid or gas through a discharge orifice at the front (open) end of the tube. The open end of the syringe may be fitted with a hypodermic needle, a nozzle or a tubing to help direct the flow into and out of the barrel. The open end of the syringe may be fitted with a cutting apparatus comprising a needle and cutting tool, as described herein.
A needle “gauge” refers to the diameter of a needle. Different gauge systems are known in the art. For purposes of referring to specific dimensions, the numerical gauge values provided herein employ the Birmingham gauge (also known as the Stubs Iron Wire Gauge or Birmingham Wire Gauge). Table 1 below provides internal and external diameter values.
Illustrative embodiments of the invention are shown in the figures. It should be understood that the invention is not limited to these particular examples.
The components of the devices may be made of any suitable material, including, but not limited to, metals, plastics, and ceramics. When used in a medical setting, the materials are preferably non-allergenic and sterilizable.
While collection of diagnostic volumes of vitreous fluid is used to highlight features and advantages of the systems, devices, and methods, the invention is not limited to this sample type or to diagnostic methods. The systems, devices, and methods find use in the collection of any sample type that can be drawn into a needle with or without the aid of the cutting tool. The systems, devices, and methods also find use in research and clinical therapeutic settings.
There are many scenarios in which small-volume liquid vitreous biopsies using the systems, devices, and methods finds use. It is currently difficult to obtain vitreous samples from patients with infectious eye diseases and eye cancers. For example, endophthalmitis, an extremely painful and vision-threatening infection of the inside of the eye (where vitreous is located), can be caused by diverse microorganisms. Determination of the correct pharmacological intervention in a given case of endophthalmitis requires identification of the causal microbe, and this necessitates sample extraction and culturing of the contained bacteria. Liquid vitreous biopsies are readily applicable to this process. Similarly, viral retinitis can result from infection by numerous types of viruses, and vitreous liquid biopsies can be used in an analogous manner to identify the causal virus and delineate the appropriate treatment. This approach can also be applied to uveitis, another infectious eye disease which can be caused by a broad spectrum of viruses, parasites, or fungi. Additionally, liquid vitreous biopsies are readily applied to ocular cancers, such as uveal melanoma and primary intraocular lymphoma.
In these contexts, analysis of vitreous fluid allows for earlier detection and more accurate predictions of prognosis. In addition to these applications, expansion of the use of liquid vitreous biopsies in a clinical setting allows for a precision-medicine approach to diagnosing and treating retinal disease and enables biomarker identification and novel therapeutic developments across a wide range of retinal diseases.
Thus, liquid biopsies provide a useful, minimally invasive approach for gleaning critical information from a given biological fluid about its abutting tissue and finds use for monitoring retinal disease status. Current devices for vitreous extraction are cumbersome, expensive, and poorly suited for small-sample aspiration, making them sub-optimal for liquid vitreous biopsy in an outpatient setting. These limitations delay definitive diagnoses and treatments. To overcome these barriers, the systems, devices, and methods provide, for example, an inexpensive, hand-held, disposable device to extract small-volume vitreous samples, enabling streamlined analysis. The systems, devices, and methods find use with ocular infections and cancers for diagnostic and pharmaceutical purposes, and facilitate a personalized approach to diagnosis, prognosis, and treatment of a more diverse set of retinal diseases.
The vitreous fluid needs to be cut for extraction to minimize the risk of retinal detachment. In some embodiments, the devices comprise a magnet attached to the cutting tool and manually actuates the cutting tool linearly and/or rotationally with a second magnet on the outside of the syringe. The design may cut and extract the fluid simultaneously. In some embodiments, a small motor is used to rotate a gear that houses an external magnet to rotate the needle. The design does not vary the speed of rotation. In some preferred embodiments, a brushless motor is employed to vary the speed of the rotation, reducing vibration and delivering a hands-free cutting action.
An exemplary device is shown in
The device of
Permanent magnet 900 has an interior channel (not shown) which is used to align and secure cutting tool 800. In this device, cutting tool 800 is a needle within a needle configuration such that the sample passes through central lumen 840 of the cutting tool 800 into syringe barrel 110. Seal or separator 930 separates the magnet from syringe tip 160 while allowing cutting tool 800 to pass through such that the sample may be transferred to syringe barrel 110. Glue hub 920 secures needle 700 to needle hub 720 with adhesive. In this device, attachment device 750 is a Luer lock connector.
A variation of the device uses the principle of the induction motor. This design does not require a magnet as the internal rotor. Instead, a similar effect is achieved through induction. The magnet is replaced by conductive loops or squirrel-cage-like part made of metal (e.g., cooper, aluminum), as shown in
Another variation of the device uses mechanical components to actuate the cutting tool. For example, a spring-like mechanism can be used to store energy and translate it into linear or rotational movement of the cutting tool. The device described herein may be used in methods of collecting samples (e.g., biological samples such as vitreous samples). In some embodiments, the method comprises: a) positioning a distal end of the needle into a region containing the sample to be collected; b) activating the actuator to rotate the cutting tool; and c) drawing sample into the collection volume. In some embodiments, the method further comprises attaching a syringe to a needle hub; removing the syringe from the needle hub; placing a cap on a collection volume for transport; and dispensing the sample from the collection volume for analysis. In some embodiments, the method is carried out without infusing material into the sample location (e.g., eye). In some embodiments, the method is carried out subsequent or prior to infusing material into the eye. In some embodiments, the method further comprises removing the syringe from the needle hub; attaching an injection fluid syringe to the needle hub, wherein the injection fluid syringe comprises a fluid to be injected; and injecting a fluid into the region. The fluid to be injected may comprise a pharmaceutical agent.
In some embodiments, collected samples are tested to identify one or more markers of interest. Identification can occur in the device or, alternatively, samples are ejected or otherwise removed from the device and tested outside of the device. In some embodiments, samples are drawn into a testing zone within the device. The testing zone comprises one or more reagents or other components that detect a marker or markers of interest. Markers of interest include, but are not limited to, proteins, peptides, nucleic acids (e.g., mRNA, microRNA, DNA, methylation status of DNA, cfDNA, etc.), hormones, metabolites, chemokines, cytokines, inflammatory markers, cancer or pre-cancer biomarkers, infectious disease agents or components or byproducts thereof, drugs and other therapeutic agents or candidate therapeutic agents, and the like. The testing zone may comprise capture particles specific for the marker(s). In some embodiments, a lateral flow strip is provided in the device that uses either a sandwich-format or a competitive format immunoassay to detect one or more markers of interest. The analysis of biomarkers find use to detect, analyze, and monitor diseases and conditions and medical interventions for such diseases and conditions including, but not limited to, infectious diseases, cancer and other proliferative diseases, diabetes (e.g., diabetic retinopathy), Alzheimer's disease, ischemic retinopathy, glaucoma, endophthalmitis, macular degeneration, vision issues, dry eye, and the like.
A prototype device was made and tested. A permanent magnet (a diametrically magnetized, nickel-plated cylinder of 0.125″+0.004″ diameter and 0.250″+0.004″ height from K&J Magnetics, Inc. (Item #D24DIA; Pipersville, Pa.)) was used. The cutting tool used was a 0.006″ diameter hollow 304 stainless steel hypodermic tubing (Item #304H34RW; MicroGroup; Medway, Mass.) or 0.004″ diameter 304 stainless steel wire (Item #9882K53; McMaster-Carr; Aurora, Ohio). Hot glue was used to attach the cutting tool and magnet to a 3D printed magnet attachment component, which was fitted into a syringe. A four-pole electromagnet motor was fixed to the outside of the syringe. The motor windings and permanent magnet allow varying of the frequency of rotation using a power amplifier and stepper motor microcontroller. Using the power amplifier and microcontroller, the internal magnet and needle rotated at set angular speeds.
The device was tested using a water sample to verify that fluid was pulled through the small cross-sectional area of the external needle with the cutting tool inside. Experiments were performed extracting milk. The sample fluids were successfully extracted with and without the cutting tool rotating. However, the data showed that when the motor is running, the extraction time is faster (>10% faster).
In addition, in experiments performed with egg yolk this design mechanism prevented the needle from clogging, as observed for a standard syringe without a cutting tool.
This application claims the benefit of U.S. Provisional Application No. 62/850,913, filed May 21, 2019, the entire contents of which are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/033995 | 5/21/2021 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62850913 | May 2019 | US |